Global Irritable Bowel Syndrome (IBS) Diagnostics Market Forecast to 2028 - COVID-19 Impact and Analysis
Share: ResearchAndMarkets.coms offering. The global irritable bowel syndrome (IBS) diagnostics market is expected to reach US$ 3,880.91 million by 2028 from US$ 2,470.61 million in 2020; it is estimated to grow at a CAGR of 5.80% from 2020 to 2028. Increasing prevalence of irritable bowel syndrome and associated conditions and increasing number of FDA approvals and diagnostics developments are the factors driving the global irritable bowel syndrome (IBS) diagnostics market. However, the challe...
United States New Zealand Asia Pacific Biohit Oyj Laura Wood International Foundation For Gastrointestinal Disorders
Source: benzinga.com